|
|
|
| Expression and Clinical Significance of miR-449a in Lung Cancer Tissue |
| LI Mei-Ling, ZHANG Guang-Ying |
| Department of Oncology,Changsha Central Hospital,Hunan 410006 |
|
|
|
|
Abstract 【Objective】To investigate the expression of microrna-449a (miR-449a) in lung cancer and its clinical significance.【Methods】 The specimens of cancer tissues and their corresponding adjacent tissues from 108 patients with lung cancer confirmed by pathology were collected, and the expression of miR-449a was detected by real-time quantitative polymerase chain reaction (RT-PCR) to determine the correlation between the expression of miR-449a in lung cancer and clinicopathological features and prognosis of lung cancer patients.【Results】 The expression of miR-449a in lung cancer was significantly lower than that in adjacent tissues (P<0.05); The expression level of miR-449a was significantly correlated with clinical stage and lymph node metastasis (P<0.05). The median survival time of high expression of miR-449a was higher than that of low expression (P<0.05).【Conclusion】 The expression of mir-449a is low in lung cancer. The expression of mir-449a is closely related to clinical stage, lymph node metastasis and prognosis.
|
|
Received: 29 July 2021
|
|
|
|
|
|
[1] BADE B C, DELA CRUZ CS. Lung cancer 2020: Epidemiology, etiology, and prevention[J].Clin Chest Med,2020,41(1):1-24.
[2] OUDKERK M, LIU S, HEUVELMANS M A,et al. Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives[J].Nat Rev Clin Oncol,2021,18(3):135-151.
[3] TODEN S, ZUMWALT T J, GOEL A. Non-coding RNAs and potential therapeutic targeting in cancer[J].Biochim Biophys Acta Rev Cancer,2021,1875(1):188491.
[4] LU T X, ROTHENBERG M E. MicroRNA[J].J Allergy Clin Immunol,2018,141(4):1202-1207.
[5] VALIHRACH L, ANDROVIC P, KUBISTA M. Circulating miRNA analysis for cancer diagnostics and therapy[J].Mol Aspects Med,2020,72:100825.
[6] WU M, WANG G, TIAN W, et al. MiRNA-based therapeutics for lung cancer[J].Curr Pharm Des,2018,23(39):5989-5996.
[7] CHEN W, LIU Y, CHEN H, et al. Loss of miR-449a-caused PrLZ overexpression promotes prostate cancer metastasis[J].Int J Oncol,2017,51(2):435-444.
[8] YE W, XUE J, ZHANG Q, et al. MiR-449a functions as a tumor suppressor in endometrial cancer by targeting CDC25A[J].Oncol Rep,2014,32(3):1193-1199.
[9] YOU J, ZHANG Y, LI Y, et al. MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer[J].Am J Cancer Res,2015,5(9):2730-2744.
[10] LI F, LIANG J, BAI L. MicroRNA-449a functions as a tumor suppressor in pancreatic cancer by the epigenetic regulation of ATDC expression[J].Biomed Pharmacother,2018,103:782-789.
[11] ISHIKAWA D, TAKASU C, KASHIHARA H,et al. The significance of microrna-449a and its potential target HDAC1 in patients with colorectal cancer[J].Anticancer Res,2019,39(6):2855-2860.
[12] WU X, HAN Y, LIU F, et al. Downregulations of miR-449a and miR-145-5p act as prognostic biomarkers for endometrial cancer[J].J Comput Biol,2020,27(5):834-844. |
|
|
|
2021, Vol. 38 
